Skip to main content
. 2022 Feb 24;12(3):579. doi: 10.3390/diagnostics12030579

Figure 4.

Figure 4

IHC mosaic patterns of p53: (a) Partly intense immunoreactivity in the field of papillary serous carcinoma; (b) zonal heterogeneity observed in an endometrioid carcinoma.